Jeffrey Glaser, MD
Pain Medicine · Encino, CANPI 1154357010
Payments from drug & device makers
Across 875 payments — averaging $188.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$83K
- Abbott$49K
- Biohaven Pharmaceuticals, Inc.$11K
- Biohaven Pharmaceutical Holding Company Ltd.$6K
- Boston Scientific$6K
- Nevro Corp.$3K
- plus $6K from 30 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 132 | $82,759 |
| Abbott | 370 | $49,334 |
| Biohaven Pharmaceuticals, Inc. | 42 | $10,839 |
| Biohaven Pharmaceutical Holding Company Ltd. | 18 | $6,420 |
| Boston Scientific | 126 | $6,077 |
| Nevro Corp. | 45 | $3,372 |
| Vertiflex, Inc. | 20 | $1,806 |
| Nalu Medical, Inc. | 12 | $1,195 |
| Globus Medical | 8 | $488 |
| Amgen(2 entities) | 20 | $263 |
| Biotronik NRO, Inc. | 6 | $251 |
| Axsome Therapeutics, Inc. | 8 | $200 |
| Teva Pharmaceuticals USA, Inc. | 9 | $167 |
| Lilly USA, LLC | 5 | $133 |
| Scilex Pharmaceuticals Inc. | 6 | $105 |
| Pfizer | 4 | $103 |
| Stryker | 3 | $99 |
| Spinesmith Holdings, LLC | 2 | $83 |
| Arbor Pharmaceuticals, Inc. | 4 | $82 |
| Redhill Biopharma Inc. | 4 | $77 |
| Intersect ENT, Inc. | 1 | $74 |
| Assertio Therapeutics, Inc. | 4 | $68 |
| Medtronic | 4 | $63 |
| Relievant Medsystems, Inc. | 3 | $60 |
| Zyla Life Sciences, Inc. | 3 | $51 |
| Stimwave Technologies Incorporated | 2 | $48 |
| DJO, LLC | 2 | $47 |
| Azurity Pharmaceuticals, Inc. | 2 | $46 |
| Bioventus LLC | 1 | $45 |
| Forte Bio-pharma LLC | 1 | $43 |
| Shionogi Inc | 2 | $34 |
| IBSA Pharma Inc. | 2 | $34 |
| Impel Pharmaceuticals Inc. | 1 | $22 |
| Almatica Pharma LLC | 1 | $21 |
| SPR Therapeutics, Inc | 1 | $19 |
| AstraZeneca | 1 | $14 |
How this compares
$164,540 in reported general payments places this provider in the 95th percentile of 840 pain medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pain medicine in Encino
- Eric GrigsbyNapa$3.2M
- Jason PopeSanta Rosa$2.8M
- Javid GhandehariSanta Monica$2.7M
- Alexander HerselThousand Oaks$2.1M
- Krishnan ChakravarthyTemecula$1.9M
- Kasra AmirdelfanWalnut Creek$1.7M
- Ramana NaiduLarkspur$1.6M
- Foead GeulaStudio City$1.3M
- Xiang QianRedwood City$941K
- Jacqueline WeisbeinNapa$863K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.